Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Increase (Decrease) in Other Receivables

2.8 / 5 stars · 68/120 Roast Me

NIAGEN BIOSCIENCE, INC. Increase (Decrease) in Other Receivables

NIAGEN BIOSCIENCE, INC. (NAGE) reported Increase (Decrease) in Other Receivables of -$1.14 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2026-08-04

  • NIAGEN BIOSCIENCE, INC. increase (decrease) in other receivables for the quarter ending 2026-06-30 was -$4.55M, a 269.11% decline year-over-year.
  • NIAGEN BIOSCIENCE, INC. increase (decrease) in other receivables for the quarter ending 2026-03-31 was $3.41M.
  • NIAGEN BIOSCIENCE, INC. increase (decrease) in other receivables for the quarter ending 2025-12-31 was $1.26M.
  • NIAGEN BIOSCIENCE, INC. increase (decrease) in other receivables for the quarter ending 2025-09-30 was -$1.16M.
  • NIAGEN BIOSCIENCE, INC. increase (decrease) in other receivables for fiscal 2025 was $756.00K, a 40.89% decline from fiscal 2024.
  • NIAGEN BIOSCIENCE, INC. increase (decrease) in other receivables for fiscal 2024 was $1.28M.
  • NIAGEN BIOSCIENCE, INC. increase (decrease) in other receivables for fiscal 2023 was -$2.25M, a 167.94% decline from fiscal 2022.
  • NIAGEN BIOSCIENCE, INC. increase (decrease) in other receivables for fiscal 2022 was $3.32M, a 28.74% increase from fiscal 2021.
Period endIncrease (Decrease) in Other Receivables 3 monthIncrease (Decrease) in Other Receivables 3 month as first filedIncrease (Decrease) in Other Receivables 6 monthIncrease (Decrease) in Other Receivables 6 month as first filedIncrease (Decrease) in Other Receivables 9 monthIncrease (Decrease) in Other Receivables 9 month as first filedIncrease (Decrease) in Other Receivables 12 monthIncrease (Decrease) in Other Receivables 12 month as first filed
2026-06-30-$4.55M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
-$1.14M
10-Q · filed 2026-08-04
$120.00K
derived: sum of 3 quarters · filed 2026-08-04
-$1.04M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31$3.41M
10-Q · filed 2026-05-06
$4.67M
derived: sum of 2 quarters · filed 2026-05-06
$3.51M
derived: sum of 3 quarters · filed 2026-05-06
$6.21M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$1.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
$100.00K
derived: sum of 2 quarters · filed 2026-03-04
$2.79M
derived: sum of 3 quarters · filed 2026-08-04
$756.00K
10-K · filed 2026-03-04
2025-09-30-$1.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$1.53M
derived: sum of 2 quarters · filed 2026-08-04
-$506.00K
10-Q · filed 2025-11-04
-$1.15M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30$2.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$656.00K
10-Q · filed 2026-08-04
$14.00K
derived: sum of 3 quarters · filed 2026-08-04
-$696.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31-$2.04M
10-Q · filed 2026-05-06
-$2.68M
derived: sum of 2 quarters · filed 2026-05-06
-$3.39M
derived: sum of 3 quarters · filed 2026-05-06
-$2.16M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31-$642.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
-$1.35M
derived: sum of 2 quarters · filed 2026-03-04
-$126.00K
derived: sum of 3 quarters · filed 2026-03-04
$1.28M
10-K · filed 2026-03-04
2024-09-30-$710.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$516.00K
derived: sum of 2 quarters · filed 2025-11-04
$1.92M
10-Q · filed 2025-11-04
$1.57M
derived: sum of 4 quarters · filed 2025-11-04
2024-06-30$1.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$2.63M
10-Q · filed 2025-08-06
$2.28M
derived: sum of 3 quarters · filed 2025-08-06
$1.96M
derived: sum of 4 quarters · filed 2025-08-06
2024-03-31$1.41M
10-Q · filed 2025-05-07
$1.06M
derived: sum of 2 quarters · filed 2025-05-07
$734.00K
derived: sum of 3 quarters · filed 2025-05-07
-$1.93M
derived: sum of 4 quarters · filed 2025-05-07
2023-12-31-$348.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04
-$671.00K
derived: sum of 2 quarters · filed 2025-03-04
-$3.34M
derived: sum of 3 quarters · filed 2025-03-04
-$2.25M
10-K · filed 2025-03-04
2023-09-30-$323.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31
-$2.99M
derived: sum of 2 quarters · filed 2024-10-31
-$1.91M
10-Q · filed 2024-10-31
$1.87M
derived: sum of 4 quarters · filed 2024-10-31
2023-06-30-$2.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
-$1.58M
10-Q · filed 2024-08-07
$2.19M
derived: sum of 3 quarters · filed 2024-08-07
$2.71M
derived: sum of 4 quarters · filed 2024-08-07
2023-03-31$1.08M
10-Q · filed 2024-05-08
$4.86M
derived: sum of 2 quarters · filed 2024-05-08
$5.38M
derived: sum of 3 quarters · filed 2024-05-08
$3.31M
derived: sum of 4 quarters · filed 2024-05-08
2022-12-31$3.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06
$4.29M
derived: sum of 2 quarters · filed 2024-03-06
$2.23M
derived: sum of 3 quarters · filed 2024-03-06
$3.32M
10-K · filed 2024-03-06
2022-09-30$522.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
-$1.55M
derived: sum of 2 quarters · filed 2023-11-08
-$454.00K
10-Q · filed 2023-11-08
-$324.00K
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30-$2.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$976.00K
10-Q · filed 2023-08-09
-$846.00K
derived: sum of 3 quarters · filed 2023-08-09
-$1.73M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$1.09M
10-Q · filed 2023-05-10
$1.22M
derived: sum of 2 quarters · filed 2023-05-10
$341.00K
derived: sum of 3 quarters · filed 2023-05-10
$1.71M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$130.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08
-$753.00K
derived: sum of 2 quarters · filed 2023-03-08
$611.00K
derived: sum of 3 quarters · filed 2023-03-08
$2.58M
10-K · filed 2023-03-08
2021-09-30-$883.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02
$481.00K
derived: sum of 2 quarters · filed 2022-11-02
$2.45M
10-Q · filed 2022-11-02
$4.70M
derived: sum of 4 quarters · filed 2022-11-02
2021-06-30$1.36M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10
$3.33M
10-Q · filed 2022-08-10
$5.58M
derived: sum of 3 quarters · filed 2022-08-10
$4.84M
derived: sum of 4 quarters · filed 2022-08-10
2021-03-31$1.97M
10-Q · filed 2022-05-12
-$1.97M
10-Q · filed 2021-05-06
$4.22M
derived: sum of 2 quarters · filed 2022-05-12
$3.47M
derived: sum of 3 quarters · filed 2022-05-12
$1.20M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$2.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14
$1.51M
derived: sum of 2 quarters · filed 2022-03-14
-$771.00K
derived: sum of 3 quarters · filed 2022-03-14
$555.00K
10-K · filed 2022-03-14
$2.06M
10-K · filed 2021-03-12
2020-09-30-$746.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03
-$3.02M
derived: sum of 2 quarters · filed 2021-11-03
-$1.70M
10-Q · filed 2021-11-03
$1.70M
10-Q · filed 2020-11-04
-$152.00K
derived: sum of 4 quarters · filed 2021-11-03
2020-06-30-$2.28M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03
-$952.00K
10-Q · filed 2021-08-03
$952.00K
10-Q · filed 2020-08-06
$594.00K
derived: sum of 3 quarters · filed 2021-08-03
$377.00K
derived: sum of 4 quarters · filed 2021-08-03
2020-03-31$1.33M
10-Q · filed 2021-05-06
$2.87M
derived: sum of 2 quarters · filed 2021-05-06
$2.65M
derived: sum of 3 quarters · filed 2021-05-06
2019-12-31$1.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
$1.33M
derived: sum of 2 quarters · filed 2021-03-12
-$44.00K
10-K · filed 2021-03-12
2019-09-30-$217.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04
-$1.59M
10-Q · filed 2020-11-04
2019-06-30-$1.37M
10-Q · filed 2020-08-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87